ATPase inhibitors of heat-shock protein 90, second season. - Archive ouverte HAL Access content directly
Journal Articles Drug Discovery Today Year : 2010

ATPase inhibitors of heat-shock protein 90, second season.

Yves L. Janin

Abstract

In the past four years, the ATP-dependent heat-shock protein 90 has remained the focus of much interest. Phase I and phase II anticancer clinical trials with first-generation inhibitors, although sometimes disappointing, have yet to report a forbidding side-effect inherent to the inhibition of this chaperone, which has a very complex and widespread role in cell biochemistry. Research in the field has started to unravel an elaborate regulation picture leading to the proper folding of many proteins. On the medicinal chemistry side, a second wave of inhibitors has been reported. This review attempts to describe all the ATPase inhibitors of HSP90 reported since our last survey.

Dates and versions

pasteur-00482094 , version 1 (08-05-2010)

Identifiers

Cite

Yves L. Janin. ATPase inhibitors of heat-shock protein 90, second season.. Drug Discovery Today, 2010, 15 (9-10), pp.342-53. ⟨10.1016/j.drudis.2010.03.002⟩. ⟨pasteur-00482094⟩

Collections

PASTEUR CNRS
30 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More